• IMA sites
  • IMA journals
  • Follow us
  • Alternate Text Alternate Text
עמוד בית
Tue, 17.11.26

March 2026 - (Issue 69)


Guest Editor's Note
Articles & Reviews
Yuval Gershon, Maya Simchoni, Linn Wagnert-Avraham, Estela Derazne, Dean Nachman, Eliraz Cohen Levi, Adi Horesh, Yaron Cohen, Maya Nitecki, Yuval Glick, Arik Eisenkraft, Nir Suissa, Gilad Twig, S. David Gertz, Ann Saada, Ariel Furer
Background: Activation of protein kinase C epsilon (PKC-
ε) enhances survival in a porcine hemorrhagic shock
model. However, the systemic biochemical and
hematological effects, particularly the multi-organ
biomarker profile, have not been fully characterized. This
study aimed to analyze laboratory biomarkers of multiorgan
injury and metabolic protection in hemorrhagic
shock treated with PKC-ε activation, including acid-base
balance, hepatic and renal function, cellular injury
markers, coagulation parameters, and endocrine stress
response.

Methods: Twenty-three female swine underwent
controlled hemorrhage (35% of blood volume). The PKC-
ε–treated group (n=15) received 3 mg/kg of a PKC-ε
activator intramuscularly five minutes after the start of
hemorrhage, while the control group (n=8) received no
drug. We monitored animals for 7 hours post-bleeding
for survival and laboratory parameters, including acidbase
balance, metabolic markers, hepatic and renal
function, coagulation, and blood count.

Results: PKC-ε activation was associated with improved
survival (73.3% vs. 25.0%, P=0.044). In the treated group,
lactate was lower, and base excess and bicarbonate were
better maintained (group-by-time interaction P=0.017,
0.022, and 0.031), and glucose was higher at hours 4 and
5 (P=0.026 and P=0.047). Hepatic injury markers did not
differ significantly between groups.

Conclusions: This study characterizes the biochemical
response to PKC-ε activation in hemorrhagic shock,
showing that the survival benefit was accompanied by
better-maintained metabolic and acid-base parameters,
with no detectable between-group differences in
coagulation. These findings describe the biochemical
profile accompanying the previously reported survival
advantage and may help generate hypotheses about
PKC-ε-mediated organ protection.
Daniel Elbo Arama, Sapir Shalom, Gal Khanchin, Ortal Ben Yosef, Dorit Nitzan, Zivan Aviad Beer
Background: On 7 October 2023, a large-scale assault on
southern Israel resulted in nearly 1,200 fatalities and the
abduction of 251 individuals, with medical personnel
among the victims. Field medical personnel provided
care under fire, fully aware that colleagues had been
wounded or killed. This study examined the challenges
these providers encountered and the factors that
enabled them to maintain professional functioning.

Methods: This qualitative descriptive study involved
semi-structured interviews conducted between
December 2023 and January 2024 with 18 Israel Defense
Forces Medical Corps field personnel (seven paramedics,
five physicians, and six medics) who provided
continuous care during the attack while aware that
colleagues had been injured or killed. All interviews were
audio-recorded, transcribed verbatim, and analyzed
using inductive, team-based thematic analysis.

Results: Participants reported overwhelming casualty
numbers, challenges in scene and evacuation
management under fire, fear for personal safety, and
recognition of acquaintances among the injured and
deceased. Five interrelated themes, each identified in at
least 13 of the 18 interviews, were found to enable
continued functioning: personal and moral dedication,
prior experience in high-stress environments, awareness
of being irreplaceable, the necessity to set aside
personal emotion and fulfill duty, and a sense that fallen
colleagues would have expected continued service.

Conclusions: Field medical personnel maintained
professional functioning under extreme threat through
moral commitment, prior experience, and a sense of
duty to patients and fallen colleagues. Training that
integrates values-based preparation, realistic stress
exposure, and structured post-event support may
enhance preparedness for combat and other mass casualty
settings.
Shani Sultani, Daniel Gelman, Danielle Akler, Liora Shmueli
Background: Accurate prehospital trauma
documentation is persistently suboptimal.
Documentation forms incorporate structurally
heterogeneous field types that impose different
cognitive demands and may respond differentially to the
documentation modality used. This study compared
documentation accuracy with paper-based, tabletbased,
and artificial intelligence-based speech
recognition (AI-SR) methods across ten data fields. It
examined whether parameter-level documentation
accuracy was consistent across methods.

Methods: A randomized crossover simulation study was
conducted among 181 advanced life support (ALS)
providers (91 physicians, 90 paramedics) in 36 teams.
Each team completed three standardized trauma
simulations using all three documentation methods in
an order randomized by Latin square. Field-level
accuracy was scored against observer-generated
reference records.

Results: Parameter rankings were highly concordant
across methods (Kendall’s W = 0.87), forming three tiers
that were identical under all methods: Safety,
Evacuation, and Cardiovascular highest (75.6–76.3%
overall), Breathing and Airway intermediate (55.4–
56.4%), and Resuscitation Round, Personal Data,
Secondary Round, Disability, and Injury lowest (37.2–
38.1%). AI-SR achieved the highest accuracy for every
parameter, followed by tablet and paper (all P < 0.001,
including Bonferroni-corrected pairwise comparisons);
its advantage over paper ranged from 28.6 to 39.2
percentage points.

Conclusions: In this simulation study, documentation
accuracy followed a parameter-level hierarchy that was
similar across paper, tablet, and AI-SR documentation.
AI-SR improved accuracy for every parameter while
largely preserving the three-tier structure, suggesting
that content-level barriers to documentation persist
across interfaces and may require targeted interventions
beyond interface design. These findings require
confirmation in operational settings.
Yeshaya Weidmann, Amir Hadid, Liran Reches, Malkah Sokol, Dor Buganim Harari, Max Miller, Yair Zack, Sharon Ogen, Tomer Erlich, Itay Ketko
Background
Extremity hemorrhage remains a leading cause of
preventable death in combat trauma, and tourniquets
are central to Tactical Combat Casualty Care. Manual
windlass tourniquets are effective but remain dependent
on correct placement, adequate tightening,
reassessment, and user skill. Emerging automatic
tourniquet technologies may reduce operator
dependence but require structured preclinical
evaluation before operational use. This study aimed to
develop and apply a requirements-driven biomedical
engineering framework within the Israel Defense Forces
Medical Corps to guide preclinical evaluation of
emerging automatic combat tourniquet technologies.

Methods
The proposed framework linked operational
requirements to engineering tests and staged release
decisions. It integrated operational requirements,
benchmarking against Combat Application Tourniquet
(CAT) reference standards, architecture screening,
simulator testing, surface pressure mapping, iterative
refinement, and proposed manufacturing and releasereadiness
criteria.

Results
Ten reference CATs generated 280.4 ± 29.5 mmHg after
four complete windlass turns and required 2.30 ± 0.48
180-degree turns to reach 200 mmHg (mean ± standard
deviation). CAT calibration supported a standardized
mid-thigh simulator application location. Prototype
efficacy and production-lot acceptance are not
established by the reported results.

Conclusions
Pre-fielding evaluation of automatic combat tourniquets
should not rely on pressure generation alone. A staged
requirements-driven framework that integrates
operational requirements, reference benchmarking,
simulator pressure testing, surface pressure mapping,
usability considerations, and manufacturing readiness
may support safer and more disciplined progression
from prototype development to clinical validation and
role-specific operational evaluation.
Ittai Peer, Inbal Gozani, Guy Vishnevsky, Jessie Oppenheimer, Yuval Raveh, Inbal Dym, Harel Gershgoren, Gal Khanchin, Danielle Akler, Bar Zemer‑Tov Schwartz, Michael Malkin, Pavel Eidelman, Teva Amir, Akiva Esterson, Aviv Gelber, Avi Benov, Arthur Shapiro
Jacob Weissmehl, Carmel Kalla
Nightmares constitute a major symptom of posttraumatic
stress disorder (PTSD) and are linked to
distress, impaired sleep quality, psychiatric
comorbidity, and increased suicide risk. The
neurobiological mechanisms underlying PTSD-related
nightmares only partially overlap with those of
insomnia, signaling a need for specific therapeutic
approaches. This review summarizes the current
evidence on pharmacological treatments for
nightmares associated with PTSD, focusing on efficacy,
tolerability, and quality of evidence. A narrative review
of the literature was carried out using PubMed and
Google Scholar for publications up to 1 July 2025.
English-language studies of pharmacological
interventions focused on reducing nightmare
frequency or severity in adults with PTSD were
included. Randomized controlled trials (RCTs),
observational studies (including open-label studies
and chart reviews), case series, and systematic reviews
and meta-analyses were considered. Efficacy,
adherence, and adverse effects were evaluated.
Alpha-1 adrenergic antagonists, particularly prazosin,
are the most extensively studied agents and have
demonstrated modest benefit in multiple trials and
meta-analyses, although large RCTs have produced
mixed results. Other adrenergic agents (such as
doxazosin and clonidine), cannabinoid-based
treatments (such as nabilone), sedating
antidepressants, and second-generation
antipsychotics have shown preliminary or adjunctive
benefits, primarily in small or methodologically limited
studies. Adverse effects, including hypotension,
metabolic complications, and daytime sedation,
restrict the widespread use of several agents. No
pharmacological treatment has demonstrated
unequivocal efficacy for PTSD-related nightmares in
large, high-quality trials. Current evidence supports
cautious, individualized use of selected agents, with
careful risk–benefit assessment. Large, well-designed
RCTs are needed to establish clear treatment
recommendations.
Leonid Barski, Ory Rouvio, Elli Rosenberg, Lior Zeller, Mahmoud Abu-Shakra, Ilia Polishchuk, Victor Novack, Carmi Bartal, Dan Schwarzfuchs, Galia Karp Kahana, Alan Jotkowitz, Vadim Sokolsky, Shosh Peleg, Shlomi Codish
Medical centers in conflict zones face unique challenges
in maintaining patient care during direct infrastructure
attacks. We describe the immediate and ongoing
response of the Internal Medicine Division at Soroka
University Medical Center to a direct missile strike that
severely compromised its inpatient facilities.
On June 19, 2025, an Iranian ballistic missile struck the
medical center, severely damaging the buildings that
housed all seven internal medicine wards. Before
impact, the hospital's emergency preparedness team
relocated all patients: ventilated and bedridden patients
to protected areas and mobile patients to partially
protected areas. With one department destroyed and the
others severely damaged, the Division rapidly
established alternative care sites: an emergency
hospitalization area in a protected basement, a
department relocated to a private hospital, and existing
protected areas. Other patients were transferred to other
hospitals.
Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel